fbpx

GBM Awareness Day is July 17. Join us in raising awareness all month long! Learn more.

MindMatters White Logo

Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.

Subscribe to MindMatters

ABTA Announces 2019 Lucien Rubinstein Award Recipient

The American Brain Tumor Association has awarded the 2019 Rubinstein Award to Nyle Almeida for his project, “Synaptogenic Glioma Cell Enrichment in High Connectivity Regions of Adult Glioma.” Nyle, a 2019 ABTA Medical Student Summer Fellowship recipient, is a second year medical student at University of Oklahoma College of Medicine. He chose to spend his summer learning neuro-oncology research with Shawn Hervey-Jumper, MD, a neurosurgeon at University of California, San Francisco.

Under Dr. Hervey-Jumper’s mentorship, Nyle conducted research focused on how certain areas within a glioma tumor can make connections with normal brain cells. The connections may help the neurons responsible for cognition (thinking and learning) work better. Their goal is to harness these connections to improve cognitive outcomes and quality of life for glioma patients.

Dr. Hervey-Jumper has been a supportive mentor to Nyle for two summers and says, “Nyle is undoubtedly a highly driven and passionate medical student, and I believe he’s more committed now than ever to a career as a neurosurgeon neuro-oncologist.”

The Lucien Rubinstein Award is given to the Medical Student Summer Fellowship recipient who scores the highest marks from a panel of expert scientific reviewers on his/her project’s final progress report. Recipients of this award receive $1,000 in recognition of their outstanding work. The award is named in honor of the late Lucien J. Rubinstein, MD, who was a pioneer in neuropathology at the University of Virginia and a world-renowned brain tumor researcher.

The ABTA would like to thank the scientific reviewers for their insightful review of all applications. For more information about research funded by the American Brain Tumor Association, visit https://www.abta.org/research/research-funding-impact/.


 

Advancing Brain Tumor Research and Support

Thanks to the generous support of donors like you, the American Brain Tumor Association has invested over $35 million in life-changing brain tumor research, helping pave the way for breakthroughs like the FDA approval of vorasidenib, a groundbreaking treatment for low-grade glioma. Through our Meet Hope Head On campaign, we continue funding critical research and providing free resources for patients and caregivers—bringing hope and advancing care for the brain tumor community.

Share This Content:

Share:

More Posts

Upcoming Events

Educational Resources

Always free for patients & caregivers

Gina & Tim Abbas
Caregiver & Anaplastic Astrocytoma Survivor

Double Your Impact for Brain Tumor Families

Donate now and your gift will be matched thanks to the Will Hicks Charitable Association.